+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

G

Actively Recruiting

Researchers are evaluating the safety and effects of Transcranial Pulse Wave Stimulation TPS in treating Alzheimers disease through a multicenter, prospective Post-Market Clinical Follow-up study. This study aims to optimize the TPS stimulation protocol and document any adverse effects, as well as track cognitive, emotional, and subjective changes in patients with Alzheimers. It focuses on patients with clinically diagnosed Alzheimers syndrome characterized by progressive memory decline and daily living impairments. Participants undergo TPS treatment under the supervision of neurological or psychiatric specialists at specialized centers. The study collects clinical data during and after treatment, including neuropsychological assessments such as the Mini Mental State Examination MMSE, Alzheimers Disease Assessment Scale ADAS, Clinical Dementia Rating, and others. Biomarker data from MRI, CSF, or PET scans may also be included if available. Treatment and data collection are part of routine care, and adverse events are carefully recorded. Throughout the study, participants are monitored for adverse events and changes in cognitive and functional status using various scales at baseline, after initial sessions, and at 3, 6, 9, and 12 months. The main outcomes include the frequency and severity of adverse events related to the device and treatment safety. This observational registry spans approximately one year, offering comprehensive follow-up to understand the impact of TPS on Alzheimers disease progression.

Age: 18Years - 85YearsAll Genders
6 locations